E., Ravuri, C., and Moens, U
The real question is whether patients will access these substances through licensed pharmacies, qualified prescribers, testing, traceability, and clinical oversight, or continue being pushed toward an unregulated research market
2026 mein: effervescent format (not capsule), 500mg dose, ALA + NAC co-factors, FSSAI number on label, GMP manufacturing, aur Japanese-fermented glutathione source
SM and KM: investigation
If underlying biomarkers or genetic context suggests an alternative intervention might be more beneficial, your provider can help prioritize that first